Bain Capital Life Sciences Fund II, L.P.
CIK
1773187
13D Filings
8
Companies
5
Latest Filing
Mar 10, 2026, 05:00 PM
Filing History
Company | % Owned | Type | Filed | |
|---|---|---|---|---|
Solid Biosciences Inc. SLDB | 8.80% ▲ +1.00% | Amendment | Mar 10, 2026, 05:00 PM | |
Mersana Therapeutics, Inc. MRSN | 0.00% ▼ -4.00% | Amendment | Jan 8, 2026, 04:30 PM | |
NewAmsterdam Pharma Company N.V. NAMS | 4.70% ▼ -5.29% | Amendment | Dec 4, 2025, 04:30 PM | |
Mersana Therapeutics, Inc. MRSN | 4.00% | Amendment | Nov 13, 2025, 06:45 PM | |
NewAmsterdam Pharma Company N.V. NAMS | 9.99% | Amendment | Nov 7, 2025, 07:19 PM | |
X4 PHARMACEUTICALS, INC. XFOR | 9.99% | NEW | Aug 13, 2025, 09:40 PM | |
Savara Inc. SVRA | 9.99% | Amendment | Mar 27, 2025, 05:40 PM | |
Solid Biosciences Inc. SLDB | 7.80% | Amendment | Feb 21, 2025, 06:04 PM | |
Rows:
20
1–8 of 8
1